Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.000x
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) has a cash flow conversion efficiency ratio of 0.000x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-56.52K) by net assets ($193.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oaktree Acquisition Corp. III Life Sciences Unit - Cash Flow Conversion Efficiency Trend (2024–2024)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Unit's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oaktree Acquisition Corp. III Life Sciences Unit Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Unit ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PSMC CO. Ltd
KQ:024850
|
-0.032x |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
-0.128x |
|
Shanghai Xin Nanyang Co Ltd
SHG:600661
|
-0.067x |
|
Ads Tec Energy PLC
NASDAQ:ADSE
|
2.025x |
|
Anhui Huaertai Chemical Co Ltd
SHE:001217
|
0.052x |
|
Kambi Group plc
PINK:KMBIF
|
0.056x |
|
Amazing Microelectronic
TWO:6411
|
0.008x |
|
GLOBALSTAR INC. DL -0001
F:P8S
|
N/A |
Annual Cash Flow Conversion Efficiency for Oaktree Acquisition Corp. III Life Sciences Unit (2024–2024)
The table below shows the annual cash flow conversion efficiency of Oaktree Acquisition Corp. III Life Sciences Unit from 2024 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $187.50 Million | $-89.69K | 0.000x | -- |